Navigation Links
Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
Date:12/5/2007

BETHESDA, Md., Dec. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammation and autoimmune diseases, today announced that Dr. Christian Itin, President and Chief Executive Officer of Micromet, will be part of a panel discussion titled "Delivering On The Promise Of Antibody Therapies For Cancer" at the 2007 RBC Capital Markets Healthcare Conference in New York, on Wednesday, December 12, 2007 at 3:30pm Eastern Time (9:30pm Central European Time).

An audio webcast of Dr. Itin's remarks will be available live and accessible through Micromet's website at http://www.micromet-inc.com, as well as a replay and download of the presentation slides following the event.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are in clinical development. MT103 (MEDI-538), the first antibody developed using the BiTE(R) technology platform to be clinically validated in Micromet's product pipeline, is being evaluated in a phase 1 clinical trial for the treatment of patients with non- Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, a subsidiary of AstraZeneca plc. The second clinical stage antibody is adecatumumab (MT201), a human monoclonal antibody targeting EpCAM expressing tumors. Adecatumumab is being developed by Micromet in collaboration with Merck Serono, a division of Merck KGaA in Darmstadt, Germany, in a phase 1b clinical trial evaluating MT201 in combination
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 a2z Inc. announces that AACC ... AACC Pathfinder, in its 2014 Annual Meeting & ... is planned for July 29-31, 2014 in Chicago, IL ... to connect with global leaders in clinical chemistry, molecular ... areas of breaking science in laboratory medicine. , ChirpE ...
(Date:7/22/2014)... Web) July 21, 2014 (PRWEB) July 23, 2014 ... Biomaterials, at Rutgers University. , The goal ... ideas across the full spectrum of scientists working ... research and development topics that represent the most ... been programmed to:,     Provide faculty ...
(Date:7/22/2014)... National Institute of Standards and Technology (NIST) and ... new design for an atomic clock that is ... microcomb. , The microcomb clock, featured on the ... journal Optica ,* is the first demonstration ... accurate conversion of optical frequencies to lower microwave ...
(Date:7/22/2014)... 22, 2014   BioTE Medical , a ... bio-identical hormone pellets, today announced the addition of ... company.   Dr. Rouzier is joining the BioTE Medical ... Dr. Rouzier was residency trained in Family ... a board certified emergency physician still practicing at ...
Breaking Biology Technology:AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2'Comb on a chip' powers new NIST/Caltech atomic clock design 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3
... at Ohio State University have invented a lens that enables ... once to create a 3D image. Other 3D microscopes ... the new lens is the first single, stationary lens to ... professor of integrated systems engineering at Ohio State, and postdoctoral ...
... 2011 Coinstar, Inc. (Nasdaq: CSTR ... a consumer-driven healthcare technology company that develops and ... award-winning EyeSite® product and the next-generation SoloHealth Station™. ... "As a leader in automated retail, Coinstar is ...
... Tomo will auction a patent portfolio disclosing an ... ICAP Ocean Tomo Spring 2011 Live IP Auction in ... improvements to existing nebulizer devices. (Logo:   ... the use of nebulizers for pulmonary drug delivery to ...
Cached Biology Technology:Seeing in stereo: Engineers invent lens for 3-D microscope 2Coinstar to Invest in SoloHealth 2Coinstar to Invest in SoloHealth 3ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 2ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 3ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 4
(Date:7/22/2014)... squirrels have adapted to New York City,s human behaviour, ... better, than their fellow squirrels in the woods. , ... Environment & Agriculture, led the study that proved eastern ... urban environments and prevent unnecessary responses when humans acted ... footpath. , "As we rapidly increase the spread ...
(Date:7/22/2014)... The darker side of meerkats which sees them prevent ... explained in a new study. , Research into the desert ... pair and many adult helpers shows that the alpha ... breed. , The study shows how this way of life, ... can prove effective despite its sinister side. , Dominant ...
(Date:7/21/2014)... of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the ... the virus. The work, published this week in ... Society for Microbiology, indicates that further studies are needed ... the air. , MERS, a serious viral respiratory illness ... people as of June 11, according to the World ...
Breaking Biology News(10 mins):New York squirrels are nuts about city life 2Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... demonstrated how nerve stimulation paired with specific experiences, such as ... lead to new treatments for stroke, tinnitus, autism and other ... at Dallas neuroscientists showed that they could alter the speed ... stimulation of the vagus nerve with fast or slow sounds. ...
... This release is available in German . ... are found to be spread widely throughout the oceans ... Antarctica. They live freely in the water, in sediments and ... for their pink colour. Marine bacteria distinguish themselves through an ...
... Baby Boomers to eat its spinach. Today, role models such ... eating habits, a recent Cornell University study finds. , "Fast ... their parents. Simply instructing a parent to order healthier food ... easy for a parent," said Brian Wansink, Cornell professor of ...
Cached Biology News:Reorganizing brain could lead to new stroke, tinnitus treatments 2Reorganizing brain could lead to new stroke, tinnitus treatments 3Think pink! Success of pink bacteria in oceans of the world 2Think pink! Success of pink bacteria in oceans of the world 3
BD BioCoat Gelatin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of gelatin....
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
... 5-OxoETE-d7 is used as an internal ... stable isotope dilution mass spectrometry. 5-OxoETE is ... oxidation of 5-HETE in human neutrophils. It ... an EC50 of 2 nM. 5-OxoETE selectively ...
...
Biology Products: